Abstract
Alveolar macrophages abundantly express PPAR-
Alveolar macrophages abundantly express PPAR-
J. V. Ravetch and S. Bolland, “IgG Fc receptors,” Annual Review of Immunology, vol. 19, pp. 275–290, 2001.
View at: Publisher Site | Google ScholarE. J. Brown, “Complement receptors, adhesion, and phagocytosis,” Infectious Agents and Disease, vol. 1, no. 2, pp. 63–70, 1992.
View at: Google ScholarS. Akira, “TLR signaling,” Current Topics in Microbiology and Immunology, vol. 311, pp. 1–16, 2006.
View at: Google ScholarA. Palecanda and L. Kobzik, “Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors,” Current Molecular Medicine, vol. 1, no. 5, pp. 589–595, 2001.
View at: Publisher Site | Google ScholarK. Asada, S. Sasaki, T. Suda, K. Chida, and H. Nakamura, “Antiinflammatory roles of peroxisome proliferator-activated receptor in human alveolar macrophages,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 2, pp. 195–200, 2004.
View at: Publisher Site | Google ScholarR. C. Reddy, V. G. Keshamouni, S. H. Jaigirdar et al., “Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor- ligands,” American Journal of Physiology, vol. 286, no. 3, pp. L613–L619, 2004.
View at: Google ScholarM. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor- is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998.
View at: Publisher Site | Google ScholarT. J. Standiford, V. C. Keshamouni, and R. C. Reddy, “Peroxisome proliferator-activated receptor- as a regulator of lung inflammation and repair,” Proceedings of the American Thoracic Society, vol. 2, no. 3, pp. 226–231, 2005.
View at: Publisher Site | Google ScholarK. Shimizu, M. Kobayashi, J. Tahara, and K. Shiratori, “Cytokines and peroxisome proliferator-activated receptor ligand regulate phagocytosis by pancreatic stellate cells,” Gastroenterology, vol. 128, no. 7, pp. 2105–2118, 2005.
View at: Publisher Site | Google ScholarM. J. Greenberger, R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford, “Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia,” The Journal of Immunology, vol. 155, no. 2, pp. 722–729, 1995.
View at: Google ScholarM. Peters-Golden and P. Thebert, “Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages,” American Review of Respiratory Disease, vol. 135, no. 5, pp. 1020–1026, 1987.
View at: Google ScholarM. Peters-Golden, R. W. McNish, R. Hyzy, C. Shelly, and G. B. Toews, “Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung,” The Journal of Immunology, vol. 144, no. 1, pp. 263–270, 1990.
View at: Google ScholarD. M. Aronoff, C. Canetti, and M. Peters-Golden, “Prostaglandin inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP,” The Journal of Immunology, vol. 173, no. 1, pp. 559–565, 2004.
View at: Google ScholarC. Smacchia, P. Rebulla, F. Drago, F. Morelati, M. Pappalettera, and G. Sirchia, “A micro colorimetric assay using cryopreserved monocytes to evaluate antibody-mediated red cell-monocyte interaction,” Haematologica, vol. 82, no. 5, pp. 526–531, 1997.
View at: Google ScholarD. M. Aronoff, C. Canetti, and M. Peters-Golden, “Prostaglandin inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP,” The Journal of Immunology, vol. 173, no. 1, pp. 559–565, 2004.
View at: Google ScholarP. Mancuso, T. J. Standiford, T. Marshall, and M. Peters-Golden, “5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae,” Infection and Immunity, vol. 66, no. 11, pp. 5140–5146, 1998.
View at: Google ScholarP. Mancuso and M. Peters-Golden, “Modulation of alveolar macrophage phagocytosis by leukotrienes is Fc receptor-mediated and protein kinase C-dependent,” American Journal of Respiratory Cell and Molecular Biology, vol. 23, no. 6, pp. 727–733, 2000.
View at: Google ScholarC. H. Serezani, D. M. Aronoff, S. Jancar, P. Mancuso, and M. Peters-Golden, “Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase,” Blood, vol. 106, no. 3, pp. 1067–1075, 2005.
View at: Publisher Site | Google ScholarR. Peck, “A one-plate assay for macrophage bactericidal activity,” Journal of Immunological Methods, vol. 82, no. 1, pp. 131–140, 1985.
View at: Publisher Site | Google ScholarJ. E. Kolodsick, M. Peters-Golden, J. Larios, G. B. Toews, V. J. Thannickal, and B. B. Moore, “Prostaglandin inhibits fibroblast to myofibroblast transition via E. Prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 5, pp. 537–544, 2003.
View at: Publisher Site | Google ScholarC. Canetti, B. Hu, J. L. Curtis, and M. Peters-Golden, “Syk activation is a leukotriene -regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells,” Blood, vol. 102, no. 5, pp. 1877–1883, 2003.
View at: Publisher Site | Google ScholarK. Kasono, J. Nishida, H. Tamemoto et al., “Thiazolidinediones increase the number of platelets in immune thrombocytopenic purpura mice via inhibition of phagocytic activity of the reticulo-endothelial system,” Life Sciences, vol. 71, no. 17, pp. 2037–2052, 2002.
View at: Publisher Site | Google ScholarF. Turturro, R. E. Oliver III, E. Friday, I. Nissim, and T. Welbourne, “Troglitazone and pioglitazone interactions via PPAR--independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell lines,” American Journal of Physiology, vol. 292, no. 3, pp. C1137–C1146, 2007.
View at: Publisher Site | Google ScholarE. García-García and C. Rosales, “Signal transduction during Fc receptor-mediated phagocytosis,” Journal of Leukocyte Biology, vol. 72, no. 6, pp. 1092–1108, 2002.
View at: Google ScholarY. Azuma, M. Shinohara, P.-L. Wang, and K. Ohura, “15-deoxy--prostaglandin is a negative regulator of macrophage functions,” International Immunopharmacology, vol. 1, no. 12, pp. 2101–2108, 2001.
View at: Publisher Site | Google ScholarS. Gordon, S. Keshav, and L. P. Chung, “Mononuclear phagocytes: tissue distribution and functional heterogeneity,” Current Opinion in Immunology, vol. 1, no. 1, pp. 26–35, 1988.
View at: Publisher Site | Google ScholarD. A. Hume, I. L. Ross, S. R. Himes, R. T. Sasmono, C. A. Wells, and T. Ravasi, “The mononuclear phagocyte system revisited,” Journal of Leukocyte Biology, vol. 72, no. 4, pp. 621–627, 2002.
View at: Google ScholarF. S. Sutterwala, G. J. Noel, P. Salgame, and D. M. Mosser, “Reversal of proinflammatory responses by ligating the macrophage Fc receptor type I,” Journal of Experimental Medicine, vol. 188, no. 1, pp. 217–222, 1998.
View at: Publisher Site | Google ScholarP.-Y. Berclaz, Y. Shibata, J. A. Whitsett, and B. C. Trapnell, “GM-CSF, via PU.1, regulates alveolar macrophage FcR-mediated phagocytosis and the IL-18/IFN--mediated molecular connection between innate and adaptive immunity in the lung,” Blood, vol. 100, no. 12, pp. 4193–4200, 2002.
View at: Publisher Site | Google ScholarC. Bonnerot, V. Briken, V. Brachet et al., “Syk protein tyrosine kinase regulates Fc receptor -chain-mediated transport to lysosomes,” The EMBO Journal, vol. 17, no. 16, pp. 4606–4616, 1998.
View at: Publisher Site | Google ScholarE. J. Kim, K. S. Park, S. Y. Chung et al., “Peroxisome proliferator-activated receptor- activator 15-deoxy--prostaglandin inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway,” Journal of Pharmacology and Experimental Therapeutics, vol. 307, no. 2, pp. 505–517, 2003.
View at: Publisher Site | Google ScholarV. G. Keshamouni, R. C. Reddy, D. A. Arenberg et al., “Peroxisome proliferator-activated receptor- activation inhibits tumor progression in non-small-cell lung cancer,” Oncogene, vol. 23, no. 1, pp. 100–108, 2004.
View at: Publisher Site | Google ScholarM. Li, T. W. Lee, A. P. Yim, T. S. Mok, and G. G. Chen, “Apoptosis induced by troglitazone is both peroxisome proliterator-activated receptor-- and ERK-dependent in human non-small lung cancer cells,” Journal of Cellular Physiology, vol. 209, no. 2, pp. 428–438, 2006.
View at: Publisher Site | Google ScholarS. H. Kim, C. I. Yoo, H. T. Kim, J. Y. Park, C. H. Kwon, and Y. K. Kim, “Activation of peroxisome proliferator-activated receptor- (PPAR) induces cell death through MAPK-dependent mechanism in osteoblastic cells,” Toxicology and Applied Pharmacology, vol. 215, no. 2, pp. 198–207, 2006.
View at: Publisher Site | Google ScholarT. V. Petrova, K. T. Akama, and L. J. Van Eldik, “Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy--prostaglandin ,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 8, pp. 4668–4673, 1999.
View at: Publisher Site | Google ScholarB. M. Spiegelman, “PPAR in monocytes: less pain, any gain?” Cell, vol. 93, no. 2, pp. 153–155, 1998.
View at: Google Scholar